VINCRISTINE SULFATE INJ 5MG/VIAL USP DIN 00690317
Status: Cancelled Post Market
Holder: DAVID BULL LABORATORIES (PTY) LTD.
Molecule: VINCRISTINE SULFATE
Health Canada record
| Active ingredient(s) | VINCRISTINE SULFATE 5 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01CA02 VINCRISTINE |
| Original market date | 31-Dec-1989 |
| Current status date | 10-Sep-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing VINCRISTINE SULFATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02143305 | VINCRISTINE SULFATE INJECTION | TEVA CANADA LIMITED | Solution | VINCRISTINE SULFATE 1 MG | Marketed |
| 02183013 | VINCRISTINE SULFATE INJECTION USP | PFIZER CANADA ULC | Solution | VINCRISTINE SULFATE 1 MG | Marketed |
| 00611182 | ONCOVIN SOLUTION 1MG/ML | ELI LILLY CANADA INC | Liquid | VINCRISTINE SULFATE 1 MG | Cancelled Post Market |
| 00726575 | VINCRISTINE SULFATE INJ 1MG/ML USP | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | VINCRISTINE SULFATE 1 MG | Cancelled Post Market |
| 02324148 | VINCRISTINE SULFATE INJECTION | ACCORD HEALTHCARE INC | Solution | VINCRISTINE SULFATE 1 MG | Cancelled Pre Market |
| 02333198 | VINCRISTINE SULFATE INJECTION USP | UMAN PHARMA INC | Solution | VINCRISTINE SULFATE 1 MG | Cancelled Pre Market |
International API supply for VINCRISTINE SULFATE
5 valid EDQM Certificates of Suitability from 5 holders. 2 active FDA Drug Master Files.
Request a quote for VINCRISTINE SULFATE INJ 5MG/VIAL USP